encainide has been researched along with Extrasystole, Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Este, D; Sorbo, MD | 1 |
| Brezsnyak, ML; Campion, J; Corum, J; Ettinger, A; Kellen, JC; McBride, R; Schron, E; Thomas, S; Todd, L | 1 |
| Anderson, JL; Karagounis, LA; Pratt, CM; Waldo, AL | 1 |
1 review(s) available for encainide and Extrasystole, Ventricular
| Article | Year |
|---|---|
[When and how to treat ventricular ectopic beats].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Exercise Test; Humans; Incidence; Prevalence; Prognosis; Propafenone; Randomized Controlled Trials as Topic; Sodium Channel Blockers; Sports; Ventricular Premature Complexes | 2010 |
1 trial(s) available for encainide and Extrasystole, Ventricular
| Article | Year |
|---|---|
The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
Topics: Aged; Anti-Arrhythmia Agents; Critical Care; Death, Sudden, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Monitoring, Physiologic; Moricizine; Myocardial Infarction; Nursing Assessment; Survival Rate; Ventricular Premature Complexes | 1996 |
1 other study(ies) available for encainide and Extrasystole, Ventricular
| Article | Year |
|---|---|
Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Drug Approval; Drug Utilization; Encainide; Evaluation Studies as Topic; Flecainide; Humans; Linear Models; Practice Patterns, Physicians'; Survival Analysis; United States; United States Food and Drug Administration; Ventricular Premature Complexes | 1997 |